Insights into autotaxin: how to produce and present a lipid mediator

被引:157
|
作者
Moolenaar, Wouter H. [1 ]
Perrakis, Anastassis [2 ]
机构
[1] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands
关键词
LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE; PHOSPHOLIPID SUBSTRATE; LPA; ACTIVATION; IDENTIFICATION; PROMOTES; MOTILITY; PLASMA;
D O I
10.1038/nrm3188
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA). LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types. ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumour progression. However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved. Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.
引用
收藏
页码:674 / 679
页数:6
相关论文
共 50 条
  • [1] Insights into autotaxin: how to produce and present a lipid mediator
    Wouter H. Moolenaar
    Anastassis Perrakis
    Nature Reviews Molecular Cell Biology, 2011, 12 : 674 - 679
  • [2] Lipid mediator signaling: structural and evolutionary insights
    Raman, C. S.
    Lee, D. S.
    Nioche, P.
    Hamberg, M.
    FEBS JOURNAL, 2009, 276 : 21 - 21
  • [3] AUTOTAXIN IS A POTENTIAL MEDIATOR OF CHOLESTATIC PRURITUS
    Kremer, Andreas E.
    Martens, Job J.
    Kulik, Wim
    Williamson, Catherine
    Moolenaar, Wouter H.
    Kondrackiene, Jurate
    Beuers, Ulrich
    Elferink, Ronald P. J. Oude
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 702 - 702
  • [4] Transformation and potentialization: how to extend the present and produce possibilities?
    Akerstrom, Andersen Niels
    Pors, Justine Gronbaek
    KYBERNETES, 2023, 52 (12) : 5893 - 5908
  • [5] Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer
    Benesch, Matthew G. K.
    Ko, Yi M.
    Tang, Xiaoyun
    Dewald, Jay
    Lopez-Campistrous, Ana
    Zhao, Yuan Y.
    Lai, Raymond
    Curtis, Jonathan M.
    Brindley, David N.
    McMullen, Todd P. W.
    ENDOCRINE-RELATED CANCER, 2015, 22 (04) : 593 - 607
  • [6] Generation of Distinct Molecular Species of the Bioactive Lipid Mediator Lysophosphatidic Acid by Autotaxin/Lysophospholipase D Through Interaction with Platelet Integrins
    Fulkerson, Zachary B.
    Sunkara, Manjula
    Drennan, Tracy
    Kooi, Craig Vander
    Morris, Andrew J.
    Smyth, Susan S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E14 - E14
  • [7] Characterization of non-lipid autotaxin inhibitors
    Hoeglund, Adrienne B.
    Howard, Angela L.
    Wanjala, Irene W.
    Pham, Truc Chi T.
    Parrill, Abby L.
    Baker, Daniel L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (02) : 769 - 776
  • [8] Autotaxin and lipid signaling pathways as anticancer targets
    Braddock, Demetrios T.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (06) : 629 - 637
  • [9] Horse conceptuses increasingly produce autotaxin during the time of rapid expansion
    Budik, S.
    Ertl, R.
    Aurich, C.
    REPRODUCTION IN DOMESTIC ANIMALS, 2023, 58 : 193 - 193
  • [10] How can membrane lipid constituency be manipulated to produce liposomes with desired functions?
    Issler, T.
    Lisowski, S.
    Farzi, K.
    Prenner, E. J.
    NANOMEDICINE, 2025,